Medical Oncologist
CION Cancer Clinics
Hereditary myeloid malignancy predisposition, in plain language | CION Cancer Clinics
A small share of leukaemia and myelodysplastic syndrome is caused by a gene fault that was present from birth and can run in a family. CEBPA, DDX41, ETV6 and ANKRD26 are four of the genes involved. This page explains what these faults do, how they are found, who should be tested and why the answer matters when a family member may become a stem cell donor. At CION Cancer Clinics, our oncologists explain what a gene result means for you and your family, and plan the checks that follow.
BP
Medically reviewed by Dr. Basudev PokhrelConsultant Haematologist · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- What is hereditary myeloid malignancy predisposition?
- How do CEBPA, DDX41, ETV6 and ANKRD26 differ?
- How is an inherited cause usually found?
- The words you will meet, in plain language
- What knowing the cause changes
- Four things families assume about inherited leukaemia
- What this page cannot tell you
- Common questions about inherited marrow cancers
The short answer
What is hereditary myeloid malignancy predisposition?
It is the name for a group of inherited gene faults that raise the chance of blood cancers starting in the bone marrow. The main ones are myelodysplastic syndrome, where the marrow makes faulty blood cells, and acute myeloid leukaemia. The fault is present from birth and can be passed down a family.
Which genes are involved
Several genes can do this. This page covers four of them: CEBPA, DDX41, ETV6 and ANKRD26. Two others, RUNX1 and GATA2, have their own pages. Each gene behaves a little differently, but the family questions are much the same.
Why it is so easily missed
An inherited leukaemia looks like any other leukaemia under the microscope. Relatives may have had a low platelet count for years that nobody linked to cancer. Older relatives may have died of a blood illness that was never named. For a long time doctors simply did not look.
Why it is worth finding
Knowing the cause changes practical decisions. It matters most when a stem cell transplant is planned and a brother or sister is being considered as the donor. It also gives relatives with an unexplained low platelet count a proper answer, and lets carriers be watched before a problem becomes urgent.
Most leukaemia is not inherited. These faults explain a small share of cases.Four genes, four patterns
How do CEBPA, DDX41, ETV6 and ANKRD26 differ?
All four raise the chance of a marrow cancer. They differ in who is affected and when.
CEBPA
Carriers have a high chance of acute myeloid leukaemia, often in childhood or young adult life. There is usually no warning sign in the blood beforehand. After treatment, a new and separate leukaemia can arise years later, which is why long-term follow-up matters.
DDX41
The one found most often in adults. Leukaemia or myelodysplastic syndrome usually appears later in life, at the same age as ordinary leukaemia, and men seem to be affected more often. Many carriers have no relative with a known blood cancer.
ETV6
Carriers often have a low platelet count from early life, with easy bruising. The chance of blood cancers is raised, including a childhood leukaemia called acute lymphoblastic leukaemia. Some carriers also have unusually large red cells on a routine blood test.
ANKRD26
Another cause of a lifelong low platelet count, often mild. The chance of myelodysplastic syndrome and leukaemia later on is raised.
Often mistaken for
- Immune low platelets, treated for years
- A family tendency to bruise, never tested
Not sure whether this applies to you?
Ask an oncologistHow the question comes up
How is an inherited cause usually found?
-
A marrow cancer is diagnosed
Someone is diagnosed with myelodysplastic syndrome or acute myeloid leukaemia. The first job is treatment planning, and genetics is often not the first thought.
-
A clue appears
The patient is young, a relative had a blood cancer or low platelets, or the tumour gene report shows a change in one of these genes that looks as though it may have been there from birth.
-
A germline test is arranged
Blood and saliva can contain leukaemia cells, so a small skin sample or hair roots are often tested instead. This shows whether the fault is in every cell.
-
The result shapes treatment and donors
If a stem cell transplant is planned, related donors can be tested for the same fault before they are chosen.
-
The family is offered testing
Relatives can be tested for that exact fault. Those who carry it can be watched. Those who do not can stop worrying.
On your report
The words you will meet, in plain language
- Myeloid
- The family of bone marrow cells that make red cells, platelets and most white cells.
- Myelodysplastic syndrome
- A marrow condition where blood cells are made badly. It can stay steady or turn into leukaemia.
- Acute myeloid leukaemia
- A fast-growing cancer of myeloid cells. It crowds out normal blood production in the marrow.
- Platelets
- Tiny blood cells that help blood to clot. A low count shows up as easy bruising or nosebleeds.
- Germline
- Present in every cell from birth, and so it can be passed on. The opposite is somatic, meaning found only in the cancer cells.
- Predisposition
- A raised chance of developing a condition. It is not the condition itself.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Side by side
What knowing the cause changes
Inherited cause not known
Inherited cause found
A matched brother or sister may be chosen as donor
That donor is tested for the fault first
Relatives with low platelets stay unexplained
Their counts can be read in context
The family has no clear next step
Carriers can be watched with blood counts
A later leukaemia is treated as a relapse
Doctors know a new one can arise
Commonly believed
Four things families assume about inherited leukaemia
"Leukaemia is never inherited."
Most leukaemia is not, but some is. Doctors now test for these faults far more often than they did, and they are found more often than anyone expected.
"He was in his sixties, so it cannot be genetic."
DDX41 faults usually cause leukaemia later in life. Age alone does not rule an inherited cause in or out.
"A brother is always the safest donor."
A brother or sister is often the first choice. If the family has an inherited fault, that donor should be tested for it first, because a carrier's stem cells carry the same fault.
"Low platelets since childhood are nothing to worry about."
Often that is true. But a lifelong low count that runs in a family, especially with a blood cancer in a relative, is worth raising with a haematologist.
Being straight with you
What this page cannot tell you
It cannot tell you whether your family carries one of these faults, or what a result in your hand means. What your specific variant means is a question for the counsellor or haematologist who ordered the test.
Evidence is still growing
These conditions have been recognised only recently. Families studied so far are few, and very few are from India. Risk estimates, and the best way to watch carriers, are still being worked out. Be wary of anyone who gives you a precise figure.
Who this does not apply to
Most people with leukaemia, and most of their relatives, do not need this test. A single older relative with leukaemia and no other clues is the usual story. If a gene change appeared only on the leukaemia report, that belongs with your treating team and the targeted therapy pages.
These faults are dominant, so marriage between relatives does not change the chance of passing them on.Questions we are asked
Common questions about inherited marrow cancers
Who should be tested for these genes?
Usually people with myelodysplastic syndrome or acute myeloid leukaemia who are young, have a relative with a blood cancer or low platelets, or have a clue on their tumour report. Anyone being assessed as a related transplant donor in such a family is also tested.
Why do they want a skin sample instead of blood?
When someone has leukaemia, their blood and saliva can carry leukaemia cells. A fault in those cells might have arisen in the cancer. Skin or hair roots show what was there from birth, which is the question being asked.
Does a fault change how leukaemia is treated?
The first treatment is often similar. The biggest difference comes with a transplant, when donor choice matters. Your haematologist will explain whether the result changes anything in your own plan.
Can my brother still be my donor?
Possibly. He should be tested for the family fault first. If he does not carry it, he may still be a good donor. If he does, your team will usually look for another donor.
Should my children be tested?
It depends on the gene. For CEBPA and ETV6, where problems can start young, testing in childhood is sometimes discussed. For DDX41, where risk comes later, it usually waits. Your counsellor will guide you.
Is there anything a carrier can do to lower the risk?
No medicine is proven to prevent these leukaemias. What helps is regular blood counts, knowing the warning signs, avoiding tobacco, and planning donor options early, before they are urgently needed.
My result says variant of uncertain significance. What now?
It means the laboratory does not yet know whether the change matters. It should not decide treatment or donor choice on its own. Ask how you will be told if it is reclassified, and whether relatives can help clarify it.
Where can we be tested in Hyderabad?
Start with your haematologist, who can arrange counselling and the right sample. If you are not sure where to go, call the CION helpline and someone will point you to the right clinic.
Your Specialists
Meet CION's oncologists. Bring your family history or genetic report to them.
Our medical oncologists see people with a strong family history of cancer, arrange genetic counselling and testing where it fits, and plan the checks that follow.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Hematologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- GeneReviews (NCBI) — CEBPA-Associated Familial Acute Myeloid Leukemia (AML)
- MedlinePlus Genetics — ETV6 gene
- National Cancer Institute — Adult Acute Myeloid Leukemia Treatment (PDQ) – Patient Version
- National Cancer Institute — Genetic Testing for Inherited Cancer Susceptibility Syndromes
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Why adult-onset leukaemia can still be inheritedWhy age does not rule out an inherited causeCEBPA, DDX41, ETV6 and ANKRD26: which cancers and what riskThe risk each gene carries, and at what stage of lifeSurveillance for carriersThe blood checks and warning signs that matterTesting the family for these genesWho is tested next, including possible donors
Talk to us
Leukaemia or low platelets running in the family?
Tell us who was affected and at what age. We will tell you honestly whether a genetic referral makes sense, and arrange it with a haematologist if it does. One helpline serves every CION centre.